News & Updates
Stay up to date with the latest happenings in our lab, including publications, awards, and events.
Introducing RNA2PS: A Novel Computational Model to Decode RNA Behavior
In April 2026, Dr. Jorge Reñé Espinosa and his research team announced a major scientific advancement with the release of RNA2PS, a cutting-edge, sequence-specific coarse-grained computational model. This new framework successfully bridges the gap between RNA structure, thermodynamics, and…
Co-Leading the New CRIS Cancer Biophysics Research Unit with Advanced Supercomputing
Dr. Jorge Reñé Espinosa has been appointed as co-Principal Investigator of the newly established CRIS Cancer Biophysics Research Unit, leading the initiative alongside Dr. Alberto Ocaña. Based at the San Carlos Clinical Hospital Biomedical Research Foundation (IdISSC) and the Universidad Complutense…
Groundbreaking Publication in Science: Unveiling the Molecular Organization of Chromatin Condensates
In a major scientific milestone, Jorge Reñé Espinosa (Ramón y Cajal Researcher at the Universidad Complutense de Madrid) has contributed to a landmark study recently published in the prestigious journal Science. Working as part of the international Chromatin Collaborative Consortium—alongside…
Jorge Reñé Espinosa Awarded Prestigious 2024 ERC Starting Grant
Jorge Reñé Espinosa has been officially recognized by the Spanish Ministry of Science, Innovation, and Universities as one of the 33 promising young scientists in Spain to receive a highly competitive 2024 European Research Council (ERC) 'Starting Grant'. Awarded as part of the European Union’s…
Pioneering Computational Strategies to Combat Alzheimer's and ALS
As part of an ongoing mission to tackle neurodegenerative diseases, Jorge Reñé Espinosa (Ramón y Cajal Fellow at the Universidad Complutense de Madrid) recently co-authored a groundbreaking study published in The Conversation. The research, conducted by an international collaborative team from the…
Stay Connected
Follow us on social media or check back regularly for the latest updates from our lab.